KIUANA BRIGHT: Open Payments
NPI 1437584141 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,002 in 92 payments from 14 companies in 2025. Trend: 2023 $1,506 · 2024 $1,736 · 2025 $2,002
Food & beverage: $1,893Education: $109
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $449 |
| ABBVIE INC. | 19 | $377 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $319 |
| Teva Pharmaceuticals USA, Inc. | 6 | $194 |
| E.R. Squibb & Sons, L.L.C. | 9 | $157 |
| Lundbeck LLC | 8 | $146 |
| Alkermes, Inc. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 1 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
Products named: Auvelity, VRAYLAR, CAPLYTA, COBENFY, REXULTI, ARISTADA, ABILIFY MAINTENA, FANAPT.
Industry payments across LA — which companies pay providers there.
